Literature DB >> 2091948

Isolation of Flavimonas oryzihabitans (CDC group Ve-2) from catheter-induced bacteremia in an immunocompromised patient.

R Mutters1, H Köppler, T Krause.   

Abstract

Bacteria of the newly proposed genus and combination Flavimonas oryzihabitans, previously known as CDC group Ve-2 or Pseudomonas oryzihabitans, are uncommon pathogens. We report here the first isolation of the organism in Germany from a case of bacteremia and describe the phenotypic characteristics of the strain.

Entities:  

Mesh：

Year:  1990        PMID： 2091948     DOI： 10.1007/BF00151722

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN： 0393-2990            Impact factor:   8.082


  7 in total

1.  Group VE-2 (Chromobacterium typhiflavum) bacteremia.

Authors:  F D Pien
Journal:  J Clin Microbiol       Date:  1977-10       Impact factor: 5.948

2.  Flavimonas oryzihabitans (Pseudomonas oryzihabitans; CDC group Ve-2): an emerging pathogen in peritonitis related to continuous ambulatory peritoneal dialysis?

Authors:  J W Bendig; P J Mayes; D E Eyers; B Holmes; T T Chin
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

3.  Group Ve infection: case report of group Ve-2 septicemia and literature review.

Authors:  F D Pien; E Y Chung
Journal:  Diagn Microbiol Infect Dis       Date:  1986-07       Impact factor: 2.803

4.  Pseudomonas species Ve-2 septicemia.

Authors:  J L Gómez Garcés; J M Aguado; M A Fernández-Clúa; F Soriano
Journal:  Eur J Clin Microbiol       Date:  1986-04       Impact factor: 3.267

5.  Unusual bacterium, group Ve-2, causing peritonitis in a patient on continuous ambulatory peritoneal dialysis.

Authors:  M R Silver; T P Felegie; M I Sorkin
Journal:  J Clin Microbiol       Date:  1985-05       Impact factor: 5.948

6.  Pseudomonas sp. group Ve-2 bacterial peritonitis in a patient on continuous ambulatory peritoneal dialysis.

Authors:  I J Amber; L G Reimer
Journal:  J Clin Microbiol       Date:  1987-04       Impact factor: 5.948

7.  Postoperative infant septicemia caused by Pseudomonas luteola (CDC group Ve-1) and Pseudomonas oryzihabitans (CDC group Ve-2).

Authors:  J Freney; W Hansen; J Etienne; F Vandenesch; J Fleurette
Journal:  J Clin Microbiol       Date:  1988-06       Impact factor: 5.948
  7 in total
  5 in total

1.  Unusual clinical presentation of infection due to Flavimonas oryzihabitans.

Authors:  A Giacometti; O Cirioni; M Quarta; A M Schimizzi; M S Del Prete; G Scalise
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-09       Impact factor: 3.267

2.  Haemorrhagic papular rash associated to Flavimonas oryzihabitans bacteraemia in a child.

Authors:  A Kansouzidou; C Charitidou; E Poubrou; V D Daniilidis; H Tsagaropoulou
Journal:  Eur J Epidemiol       Date:  2000-03       Impact factor: 8.082

Review 3.  Infections due to Flavimonas oryzihabitans: case report and literature review.

Authors:  J Esteban; M L Valero-Moratalla; R Alcazar; F Soriano
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-10       Impact factor: 3.267

4.  Epidemiological typing of Flavimonas oryzihabitans by PCR and pulsed-field gel electrophoresis.

Authors:  P Y Liu; Z Y Shi; Y J Lau; B S Hu; J M Shyr; W S Tsai; Y H Lin; C Y Tseng
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

5.  In vitro activities of antimicrobial agents against clinical isolates of Flavimonas oryzihabitans obtained from patients with cancer.

Authors:  K V Rolston; D H Ho; B LeBlanc; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.